Literature DB >> 23997223

Inhibition of endogenous activated protein C attenuates experimental autoimmune encephalomyelitis by inducing myeloid-derived suppressor cells.

Leah M Alabanza1, Naomi L Esmon, Charles T Esmon, Margaret S Bynoe.   

Abstract

Activated protein C (PC) is an anticoagulant involved in the interactions between the coagulation and immune systems. Activated PC has broad anti-inflammatory effects that are mediated through its ability to modulate leukocyte function and confer vascular barrier protection. We investigated the influence of activated PC on the pathogenesis of experimental autoimmune encephalomyelitis (EAE), the animal model for multiple sclerosis. We modulated activated PC levels in the circulation during EAE induction through systemic administration of a mAb against PC/activated PC (anti-PC). We initially hypothesized that inhibition of activated PC may result in a heightened inflammatory environment, leading to increased EAE pathogenesis. Contrary to this hypothesis, mice treated with anti-PC Ab (anti-PC mice) exhibited attenuated EAE. Interestingly, despite reduced disease severity and minimal pathogenic conditions in the CNS, anti-PC mice exhibited considerable leukocyte infiltration in the brain, comparable to control mice with severe EAE. Furthermore, CD4(+) T cells were diminished in the periphery of anti-PC mice, whereas various CD11b(+) populations were increased, notably the myeloid-derived suppressor cells (MDSCs), a CD11b(+) subset characterized as potent T cell suppressors. MDSCs from anti-PC mice exhibited increased expression of T cell suppressive factors and effectively inhibited T cell proliferation. Overall, our findings show that activated PC inhibition affected EAE pathogenesis at multiple fronts, specifically increasing vascular barrier permeability, as evidenced by considerable leukocyte infiltration in the brain. Additionally, inhibition of activated PC modulated the functional responses of CD11b(+) cells, leading to the expansion and increased activation of MDSCs, which are suppressive to the CD4(+) T cells required for EAE progression, thereby resulting in attenuated EAE.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23997223      PMCID: PMC3800123          DOI: 10.4049/jimmunol.1202556

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  58 in total

1.  Alpha4-integrin-VCAM-1 binding mediates G protein-independent capture of encephalitogenic T cell blasts to CNS white matter microvessels.

Authors:  P Vajkoczy; M Laschinger; B Engelhardt
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

2.  Plasma thrombin-antithrombin III complex is associated with the severity of experimental autoimmune encephalomyelitis.

Authors:  Y Inaba; M Ichikawa; A Inoue; M Itoh; M Kyogashima; Y Sekiguchi; S Nakamura; A Komiyama; C Koh
Journal:  J Neurol Sci       Date:  2001-04-01       Impact factor: 3.181

3.  Imaging inflammation: direct visualization of perivascular cuffing in EAE by magnetic resonance microscopy.

Authors:  Paula J Gareau; Allison C Wymore; Gary P Cofer; G Allan Johnson
Journal:  J Magn Reson Imaging       Date:  2002-07       Impact factor: 4.813

4.  Neurovascular permeability and fibrin deposition in the central neuraxis of Lewis rats with cell-transferred experimental allergic encephalomyelitis in relationship to clinical and histopathological features of the disease.

Authors:  C S Koh; J Gausas; P Y Paterson
Journal:  J Neuroimmunol       Date:  1993-09       Impact factor: 3.478

5.  Determination of arginase activity in macrophages: a micromethod.

Authors:  I M Corraliza; M L Campo; G Soler; M Modolell
Journal:  J Immunol Methods       Date:  1994-09-14       Impact factor: 2.303

Review 6.  Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function.

Authors:  Thomas Condamine; Dmitry I Gabrilovich
Journal:  Trends Immunol       Date:  2010-11-08       Impact factor: 16.687

7.  L-arginine consumption by macrophages modulates the expression of CD3 zeta chain in T lymphocytes.

Authors:  Paulo C Rodriguez; Arnold H Zea; Joanna DeSalvo; Kirk S Culotta; Jovanny Zabaleta; David G Quiceno; Juan B Ochoa; Augusto C Ochoa
Journal:  J Immunol       Date:  2003-08-01       Impact factor: 5.422

Review 8.  Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammation.

Authors:  Marlies Van de Wouwer; Désiré Collen; Edward M Conway
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-06-03       Impact factor: 8.311

Review 9.  Neutrophils, nitrogen oxides, and inflammatory bowel disease.

Authors:  M B Grisham; T Yamada
Journal:  Ann N Y Acad Sci       Date:  1992       Impact factor: 5.691

10.  Activated protein C inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production by inhibiting activation of both nuclear factor-kappa B and activator protein-1 in human monocytes.

Authors:  Mehtap Yuksel; Kenji Okajima; Mitsuhiro Uchiba; Seikoh Horiuchi; Hiroaki Okabe
Journal:  Thromb Haemost       Date:  2002-08       Impact factor: 5.249

View more
  12 in total

1.  Inflammation-associated activation of coagulation and immune regulation by the protein C pathway.

Authors:  Hartmut Weiler
Journal:  Thromb Res       Date:  2014-05       Impact factor: 3.944

2.  EPCR-dependent PAR2 activation by the blood coagulation initiation complex regulates LPS-triggered interferon responses in mice.

Authors:  Hai Po H Liang; Edward J Kerschen; Irene Hernandez; Sreemanti Basu; Mark Zogg; Fady Botros; Shuang Jia; Martin J Hessner; John H Griffin; Wolfram Ruf; Hartmut Weiler
Journal:  Blood       Date:  2015-03-02       Impact factor: 22.113

3.  Myeloid-derived suppressor cells protect mouse models from autoimmune arthritis via controlling inflammatory response.

Authors:  Lei Zhang; Zhengmei Zhang; Huailiang Zhang; Min Wu; Yanxia Wang
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

Review 4.  Thrombin generation and activity in multiple sclerosis.

Authors:  Kelley R Jordan; Ivan Parra-Izquierdo; András Gruber; Joseph J Shatzel; Peter Pham; Larry S Sherman; Owen J T McCarty; Norah G Verbout
Journal:  Metab Brain Dis       Date:  2021-01-07       Impact factor: 3.584

5.  A novel antagonist of p75NTR reduces peripheral expansion and CNS trafficking of pro-inflammatory monocytes and spares function after traumatic brain injury.

Authors:  Sangmi Lee; Aaron Mattingly; Amity Lin; Jeffrey Sacramento; Leda Mannent; Marie-Noelle Castel; Benoit Canolle; Sandrine Delbary-Gossart; Badia Ferzaz; Josh M Morganti; Susanna Rosi; Adam R Ferguson; Geoffrey T Manley; Jacqueline C Bresnahan; Michael S Beattie
Journal:  J Neuroinflammation       Date:  2016-04-22       Impact factor: 8.322

Review 6.  Neuro-Immune Hemostasis: Homeostasis and Diseases in the Central Nervous System.

Authors:  Ciro De Luca; Anna Maria Colangelo; Lilia Alberghina; Michele Papa
Journal:  Front Cell Neurosci       Date:  2018-11-26       Impact factor: 5.505

7.  Activated Protein C Attenuates Experimental Autoimmune Encephalomyelitis Progression by Enhancing Vascular Integrity and Suppressing Microglial Activation.

Authors:  Ravi Kant; Sebok K Halder; Jose A Fernández; John H Griffin; Richard Milner
Journal:  Front Neurosci       Date:  2020-04-15       Impact factor: 4.677

Review 8.  Neuro-Coagulopathy: Blood Coagulation Factors in Central Nervous System Diseases.

Authors:  Ciro De Luca; Assunta Virtuoso; Nicola Maggio; Michele Papa
Journal:  Int J Mol Sci       Date:  2017-10-12       Impact factor: 5.923

9.  Myeloid-derived suppressor cells support remyelination in a murine model of multiple sclerosis by promoting oligodendrocyte precursor cell survival, proliferation, and differentiation.

Authors:  Carolina Melero-Jerez; Beatriz Fernández-Gómez; Rafael Lebrón-Galán; Maria Cristina Ortega; Irene Sánchez-de Lara; Ana Cristina Ojalvo; Diego Clemente; Fernando de Castro
Journal:  Glia       Date:  2020-11-20       Impact factor: 7.452

10.  Methylprednisolone alleviates multiple sclerosis by expanding myeloid-derived suppressor cells via glucocorticoid receptor β and S100A8/9 up-regulation.

Authors:  Zhongkun Wang; Ge Zheng; Guangjian Li; Mengkun Wang; Zhanchuan Ma; Huimin Li; Xiang-Yang Wang; Huanfa Yi
Journal:  J Cell Mol Med       Date:  2020-10-23       Impact factor: 5.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.